FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older
Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee
If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | Covid Vaccine | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Pharmaceuticals | Vaccines